- Stocks
- Healthcare
- NASDAQ: PGEN

Price (delayed)

$7.51

Market cap

$1.54B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.02

Enterprise value

$1.68B

PGEN's gross profit has surged by 63% year-on-year and by 9% since the previous quarter

Precigen's EPS has surged by 51% YoY and by 46% QoQ

PGEN's equity is up by 15% since the previous quarter but it is down by 6% year-on-year

PGEN's quick ratio is down by 36% from the previous quarter

What are the main financial stats of PGEN

Market
Valuations
Earnings

Shares outstanding

205.66M

Market cap

$1.54B

Enterprise value

$1.68B

Price to earnings (P/E)

N/A

Price to book (P/B)

20.73

Price to sales (P/S)

12.16

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

16.23

Revenue

$103.18M

EBIT

-$152.2M

EBITDA

-$134.69M

Free cash flow

-$78.06M

Per share
Balance sheet
Liquidity

EPS

-$1.02

Free cash flow per share

-$0.47

Book value per share

$0.36

Revenue per share

$0.62

TBVPS

$1.17

Total assets

$314.59M

Total liabilities

$247.41M

Debt

$182.28M

Equity

$67.17M

Working capital

$106.82M

Debt to equity

2.71

Current ratio

3.54

Quick ratio

2.77

Net debt/EBITDA

-0.97

Margins
Efficiency
Dividend

EBITDA margin

-130.5%

Gross margin

46.2%

Net margin

-165.3%

Operating margin

-84.1%

Return on assets

-48.1%

Return on equity

-259.8%

Return on invested capital

-41.8%

Return on capital employed

-55.9%

Return on sales

-147.5%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Precigen stock price performed over time

Intraday

0.27%

1 week

9.96%

1 month

-8.3%

1 year

155.44%

YTD

-26.37%

QTD

9%

How have Precigen's revenue and profit performed over time

Revenue

$103.18M

Gross profit

$47.67M

Operating income

-$86.77M

Net income

-$170.52M

Gross margin

46.2%

Net margin

-165.3%

PGEN's gross profit has surged by 63% year-on-year and by 9% since the previous quarter

PGEN's operating margin has soared by 53% YoY and by 34% from the previous quarter

Precigen's net margin has soared by 53% YoY and by 44% from the previous quarter

PGEN's net income is up by 47% year-on-year and by 43% since the previous quarter

What is Precigen's growth rate over time

What is Precigen stock price valuation

P/E

N/A

P/B

20.73

P/S

12.16

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

16.23

Precigen's EPS has surged by 51% YoY and by 46% QoQ

PGEN's P/B is 200% above its 5-year quarterly average of 6.9 and 33% above its last 4 quarters average of 15.6

PGEN's equity is up by 15% since the previous quarter but it is down by 6% year-on-year

PGEN's P/S is 33% above its last 4 quarters average of 9.1 and 17% above its 5-year quarterly average of 10.4

Precigen's revenue has increased by 14% YoY and by 2.3% from the previous quarter

How efficient is Precigen business performance

PGEN's return on equity has dropped by 80% year-on-year but it is up by 42% since the previous quarter

Precigen's return on sales has surged by 56% YoY and by 47% QoQ

The ROIC has grown by 42% from the previous quarter and by 34% YoY

The ROA has grown by 37% from the previous quarter and by 10% YoY

What is PGEN's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for PGEN.

How did Precigen financials performed over time

The company's total assets is 27% higher than its total liabilities

PGEN's current ratio has surged by 85% year-on-year but it is down by 28% since the previous quarter

PGEN's quick ratio is down by 36% from the previous quarter

Precigen's debt is 171% more than its equity

PGEN's debt to equity is down by 28% from the previous quarter and by 16% YoY

Precigen's debt has decreased by 22% YoY and by 17% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.